Splicing potentiation by growth factor signals via estrogen receptor phosphorylation

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8126-31. doi: 10.1073/pnas.0503197102. Epub 2005 May 26.

Abstract

Mitogen-activated protein kinase-mediated growth factor signals are known to augment the ligand-induced transactivation function of nuclear estrogen receptor alpha (ERalpha) through phosphorylation of Ser-118 within the ERalpha N-terminal transactivation (activation function-1) domain. We identified the spliceosome component splicing factor (SF)3a p120 as a coactivator specific for human ERalpha (hERalpha) activation function-1 that physically associated with ERalpha dependent on the phosphorylation state of Ser-118. SF3a p120 potentiated hERalpha-mediated RNA splicing, and notably, the potentiation of RNA splicing by SF3a p120 depended on hER Ser-118 phosphorylation. Thus, our findings suggest a mechanism by which growth factor signaling can regulate gene expression through the modulation of RNA splicing efficiency via phosphorylation of sequence-specific activators, after association between such activators and the spliceosome.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Line
  • Estrogen Receptor alpha / metabolism*
  • Growth Substances / pharmacology*
  • Humans
  • Mitogen-Activated Protein Kinases / metabolism
  • Phosphorylation / drug effects
  • Phosphoserine / metabolism
  • Protein Binding
  • RNA Splicing / drug effects*
  • Ribonucleoprotein, U2 Small Nuclear / chemistry
  • Ribonucleoprotein, U2 Small Nuclear / metabolism*
  • Signal Transduction / drug effects*
  • Spliceosomes / metabolism

Substances

  • Estrogen Receptor alpha
  • Growth Substances
  • Ribonucleoprotein, U2 Small Nuclear
  • splicing factor 3a
  • Phosphoserine
  • Mitogen-Activated Protein Kinases